Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

NYSE: BHVN · IEX Real-Time Price · USD
+1.00 (3.29%)
At close: Nov 27, 2023, 4:00 PM
+0.95 (3.02%)
After-hours: Nov 27, 2023, 7:55 PM EST

Total Valuation

BHVN has a market cap or net worth of $2.52 billion. The enterprise value is $2.31 billion.

Market Cap 2.52B
Enterprise Value 2.31B

Important Dates

The last earnings date was Tuesday, November 14, 2023, after market close.

Earnings Date Nov 14, 2023
Ex-Dividend Date n/a

Share Statistics

BHVN has 80.08 million shares outstanding. The number of shares has increased by 73.51% in one year.

Shares Outstanding 80.08M
Shares Change (YoY) +73.51%
Shares Change (QoQ) +0.11%
Owned by Insiders (%) 14.47%
Owned by Institutions (%) 100.97%
Float 62.16M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 8.68
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.10.

Current Ratio 5.00
Quick Ratio n/a
Debt / Equity 0.10
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -110.10% and return on invested capital (ROIC) is -155.75%.

Return on Equity (ROE) -110.10%
Return on Assets (ROA) -85.60%
Return on Capital (ROIC) -155.75%
Revenue Per Employee n/a
Profits Per Employee -$2.30M
Employee Count 202
Asset Turnover n/a
Inventory Turnover n/a


Income Tax -14.31M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +118.18% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +118.18%
50-Day Moving Average 26.23
200-Day Moving Average 20.03
Relative Strength Index (RSI) 62.39
Average Volume (30 Days) 1,185,044

Short Selling Information

The latest short interest is 6.72 million, so 8.39% of the outstanding shares have been sold short.

Short Interest 6.72M
Short Previous Month 7.12M
Short % of Shares Out 8.39%
Short % of Float 10.80%
Short Ratio (days to cover) 5.28

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -495.75M
Pretax Income -478.83M
Net Income -464.52M
EBITDA -473.47M
EBIT -478.83M
Earnings Per Share (EPS) -$7.22
Full Income Statement

Balance Sheet

The company has $240.62 million in cash and $28.29 million in debt, giving a net cash position of $212.34 million or $2.65 per share.

Cash & Cash Equivalents 240.62M
Total Debt 28.29M
Net Cash 212.34M
Net Cash Per Share $2.65
Equity / Book Value 290.01M
Book Value Per Share 3.62
Working Capital 248.39M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$292.25 million and capital expenditures -$2.88 million, giving a free cash flow of -$295.13 million.

Operating Cash Flow -292.25M
Capital Expenditures -2.88M
Free Cash Flow -295.13M
FCF Per Share -$4.32
Full Cash Flow Statement


Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BHVN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -18.45%
FCF Yield -11.72%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -73.51%
Shareholder Yield -73.51%
Dividend Details

Analyst Forecast

The average price target for BHVN is $29.40, which is -6.49% lower than the current price. The consensus rating is "Strong Buy".

Price Target $29.40
Price Target Difference -6.49%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a


Altman Z-Score n/a
Piotroski F-Score 2